Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 7 Lung Neoplasms 6 Colorectal Neoplasms 5 Prostatic Neoplasms 3 Smoking Cessation 2 Neoplasm Metastasis 2 Colonic Neoplasms 2 Uveal Melanoma 1 Stomach Neoplasms 1 Solitary Pulmonary Nodule 1 Retroviridae Infections 1 Pulmonary Disease, Chronic Obstructive 1 Pancreatic cancer, adult 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Multiple Myeloma 1 Motor Activity 1 Lymphoma 1 Inflammation 1 Glioblastoma 1 Esophageal Neoplasms 1 Dyspnea 1 Disease 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Radiosurgery 51 Magnetic Resonance Spectroscopy 34 Temozolomide 29 Bevacizumab 24 pembrolizumab 23 Radiotherapy 20 Nivolumab 20 Specimen Handling 14 Ipilimumab 13 Cyclophosphamide 13 Mental Status and Dementia Tests 12 Carboplatin 12 abemaciclib 10 Radiation 10 trastuzumab deruxtecan 8 Proton Therapy 7 Pemetrexed 7 Memantine 7 Blood Specimen Collection 7 fluciclovine F-18 6 binimetinib 6 Paclitaxel 6 Lomustine 6 Etoposide 6 Cisplatin 6 Capecitabine 6 encorafenib 5 Trastuzumab 5 Surveys and Questionnaires 5 Surgical Procedures, Operative 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Hematologic Tests × 1 year × Clear all

NCT05848050 2025-11-24

METALIQ

GCS Ramsay Santé pour l'Enseignement et la Recherche

Phase NA Completed

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡